---
name: LIDE Biotech
slug: lide-biotech
site: cro
website_domain: lidebiotech.com
summary: Oncology-focused preclinical CRO with AAALAC-accredited China-based labs offering 2300+ PDX models, MiniPDX organoid assays, and multi-omics analysis for drug discovery and development. Headquartered in China.
tagline: Oncology-focused preclinical CRO with 2300+ PDX models and AAALAC-accredited labs.
founded_year: 2011
employee_count_band: 
employee_count_label: 
parent_name: 
parent_slug: 
hq_country: CN
tier2_domain_verified: false
updated_at: 2026-08-18T11:00:22.710Z
services_count: 10
modalities_count: 2
indications_count: 2
locations_count: 1
review_signal_gate: closed
generated_by: BioBM Editorial AI
---

# LIDE Biotech

Oncology-focused preclinical CRO with 2300+ PDX models and AAALAC-accredited labs.

Listed on cro.directory.

## Summary

Oncology-focused preclinical CRO with AAALAC-accredited China-based labs offering 2300+ PDX models, MiniPDX organoid assays, and multi-omics analysis for drug discovery and development. Headquartered in China.

## At a glance

- Founded: 2011
- HQ country: CN

## Services

- Specialized & Large-Animal Models
- In Vivo Efficacy Models
- Preclinical In Vivo Studies
- In Vitro Pharmacology
- Preclinical In Vitro Studies
- Genomics & Sequencing Services
- Proteomics Services
- Oncology Specialty Services
- Immunology & Inflammation Services
- Biomarker Assays

## Modalities

- Antibody-Drug Conjugate (ADC)
- Cell Therapy

## Indications

- Oncology
- Immunology

## Locations

- Headquarters, China

## Certifications

- AAALAC; Identifier: AAALAC accredited; Source: https://lidebiotech.com/

## Long description

## Overview

LIDE Biotech is an oncology-focused preclinical contract research organization founded in 2011 by overseas returnees. The company operates AAALAC-accredited laboratories in China and provides preclinical models and services to global pharmaceutical and biotech clients.

## Core Capabilities

**Preclinical Models & Platforms:**
- 2300+ patient-derived xenograft (PDX) models across 50+ cancer types, including 400+ pre-treated and 370+ drug-resistant models
- 120+ cell line-derived xenograft (CDX) models
- Orthotopic, syngeneic, humanized, and autoimmune disease models
- Ex vivo models including 3D spheroid and organoid assays, conditionally reprogrammed (CR) cells, and co-culture assays for immuno-oncology
- MiniPDX® 7-day in vivo organoid assay with IO-FIVE® platform for immuno-oncology applications

**Analytical & Genomic Services:**
- In-house multi-omics analysis
- OncoVee™ K-Cell 1000 Cell Kit
- Transcription analysis and bioinformatics
- Sequencing and functional genomic imaging (FGI)
- Multiplex tissue imaging

**Therapeutic Focus Areas:**
- Preclinical oncology studies
- Immuno-oncology (IO) platform
- Hematological malignancies and blood cancers
- Drug-resistant cancer models
- ADC (antibody-drug conjugate) development acceleration

**Research Phases Supported:**
- Target identification and HIT discovery
- Lead optimization and preclinical validation
- Clinical testing and biomarker identification

## Differentiation

LIDE emphasizes a "preclinical focus, clinical mindset" approach, leveraging tools designed to bring preclinical studies as close as possible to clinical relevance. The company maintains global leadership with local support, offering verified quality on Scientist.com and commitment to operational excellence.

## Related companies

- [Crown Bioscience](/companies/crownbio) (Specialized & Large-Animal Models, In Vivo Efficacy Models) — [Compare](/compare/crownbio/lide-biotech)
- [Champions Oncology](/companies/championsoncology) (Specialized & Large-Animal Models, In Vivo Efficacy Models) — [Compare](/compare/championsoncology/lide-biotech)
- [Reaction Biology](/companies/reactionbiology) (Specialized & Large-Animal Models, In Vivo Efficacy Models) — [Compare](/compare/lide-biotech/reactionbiology)
- [Cyagen Biosciences](/companies/cyagen) (Specialized & Large-Animal Models, In Vivo Efficacy Models) — [Compare](/compare/cyagen/lide-biotech)
- [GemPharmatech](/companies/gempharmatech) (Specialized & Large-Animal Models, In Vivo Efficacy Models) — [Compare](/compare/gempharmatech/lide-biotech)
- [Biotest Facility](/companies/bioxpedia) (In Vivo Efficacy Models, Preclinical In Vivo Studies) — [Compare](/compare/bioxpedia/lide-biotech)
- [BioDuro-Sundia](/companies/bioduro-sundia) (Specialized & Large-Animal Models, In Vivo Efficacy Models) — [Compare](/compare/bioduro-sundia/lide-biotech)
- [Confluence Discovery Technologies, Inc.](/companies/confluencediscovery) (In Vivo Efficacy Models, In Vitro Pharmacology) — [Compare](/compare/confluencediscovery/lide-biotech)

_Profile last updated: 2026-08-18T11:00:22.710Z. Profile facts may include AI-assisted enrichment._

Auto-generated by BioBM Editorial AI for machine-readable profile access.